Oral GLP-1 drugs suppress brain's food craving circuit in mice

Oral GLP-1 drugs related to semaglutide (Ozempic) reduced pleasure-driven eating in mice by quieting a deep brain reward circuit. The finding could open new avenues for treating both food cravings and substance use disorder, researchers say.